首页 > Surrogacy fees > Is IVF in Thailand Cost-Effective? An Analysis from the Perspectives of Cost, Success Rate, and Actual Medical Experience

Is IVF in Thailand Cost-Effective? An Analysis from the Perspectives of Cost, Success Rate, and Actual Medical Experience

The cost-effectiveness of IVF in Thailand needs to be evaluated based on a combination of cost, success rate, technical suitability, and personal health conditions. This article analyzes the cost structure, success rate data, hospital differences, and suitable candidates for IVF in Thailand from a reproductive doctor's perspective, providing objective reference information.

===== Opening: Direct Answer =====

Reproductive Doctor Perspective Knowledge Base Content Patient Education

Whether IVF in Thailand is cost-effective depends on how well your medical needs match Thailand's medical resources.

A 38-year-old patient with an AMH of 1.2 ng/mL and bilateral tubal blockage once asked me directly: Is it worth going to Thailand for IVF? This question cannot be answered with a simple "yes" or "no," but it can be broken down from several core dimensions: cost structure, success rate data, technical applicability, personal health status, and hidden costs. Let's analyze step by step below.

===== Module A: Direct Answer =====

1. Core Criteria for Judging Cost-Effectiveness

The medical cost for PGT (Preimplantation Genetic Testing) in Thailand is approximately 90,000 to 150,000 RMB. Additional costs for living, translation, etc., range from about 30,000 to 60,000 RMB, making the total budget between 120,000 and 200,000 RMB. In comparison, the cost for PGT in China is about 50,000 to 100,000 RMB, and in the USA, it is about 200,000 to 300,000 RMB. Thailand sits in the middle.

In terms of success rates, top fertility centers in Thailand (such as Jetanin, BNH, Vejthani, LRC, etc.) have live birth rates of approximately 50% to 70%, which is comparable to leading centers in China (e.g., Peking University Third Hospital, Citic Xiangya). However, it is important to note that success rates are heavily influenced by age, etiology, and previous treatment history, so direct comparisons should not be made.

Three conditions for judging cost-effectiveness:

① You need PGT technology but face long waiting times or limited indications in China;

② You have experienced repeated implantation failure in China and want to change the laboratory environment and stimulation protocol;

③ Your budget is between 150,000 and 200,000 RMB, and you can accept the time cost of seeking medical treatment abroad.

If you meet any two of the above conditions, the cost-effectiveness of IVF in Thailand is relatively high. Otherwise, a top-tier public fertility center in China might be a more efficient choice.

===== Module C: Doctor's Perspective =====

2. Reproductive Doctor's Perspective: Components of Cost-Effectiveness

From a clinical standpoint, cost-effectiveness isn't just about being "cheap," but rather the probability of a live birth per 10,000 RMB spent. Factors influencing this metric include:

  • Laboratory Standards: Thailand has several world-class embryology labs with extensive experience in blastocyst culture, PGT technology, and freeze-thaw recovery. Lab quality directly impacts embryo potential.
  • Individualized Stimulation Protocols: Thai doctors see a large number of international patients and have extensive experience handling complex cases like PCOS, Poor Ovarian Response (POR), and advanced age, offering flexible protocols.
  • Medication Costs: The price of imported fertility drugs (e.g., Gonal-f, Puregon) in Thailand is similar to that in China, with some brands being slightly cheaper, but the overall difference is not significant.
  • Language and Coordination Costs: The quality of translation and the efficiency of medical coordination can indirectly affect the treatment experience and decision-making accuracy, representing hidden costs.

As a reproductive doctor, I usually advise patients to first complete a basic fertility assessment (AMH, FSH, LH, antral follicle count, semen analysis) before discussing the feasibility of overseas treatment. Discussing cost-effectiveness without an assessment lacks a solid foundation.

===== Module K: Factors Affecting Cost =====

3. Factors Affecting Cost: More Than Just Medical Fees

The cost of IVF in Thailand consists of several parts. The table below lists the main items and their approximate ranges:

Cost Item Approximate Range (RMB) Description
Ovulation Stimulation Medications 20,000 - 40,000 Varies by dosage and brand; imported drugs account for a large portion
Egg Retrieval Surgery + Lab 40,000 - 70,000 Includes Intracytoplasmic Sperm Injection (ICSI)
Embryo Culture + PGT 30,000 - 60,000 PGT-A/PGT-M prices differ; charged per embryo
Embryo Transfer + Luteal Support 15,000 - 30,000 Includes endometrial preparation, transfer procedure, and post-transfer medication
Living + Translation + Transportation 30,000 - 60,000 Based on 20-30 days; varies by lifestyle
Pre-treatment Tests + Documents 5,000 - 10,000 Completed in China; some tests are accepted by Thai hospitals

Easily overlooked are the embryo freezing fees and subsequent transfer fees. If the first transfer is unsuccessful, each frozen embryo transfer costs about 15,000 to 25,000 RMB. This cost should be reserved in the budget.

===== Module F: Differences Between Hospitals =====

4. Differences Between Hospitals: Choosing the Right Institution is More Important Than Choosing the Country

Fertility centers in Thailand vary significantly, reflected in the following aspects:

  • Laboratory Standards: Some hospitals have international CAP or JCI accreditation, with stricter quality control systems and higher embryo culture stability.
  • Doctor Background: Some doctors specialize in stimulation for advanced age, while others have extensive experience in genetic screening (PGT-M). You need to match based on your own situation.
  • Patient Source: Centers with a primarily local patient base tend to have more stable procedures; centers with a primarily international patient base have more mature translation and coordination services but may charge slightly higher fees.
  • Package Models: Some hospitals offer "success guarantee" packages (higher price with strict indication limitations), which are essentially insurance products. You need to read the terms carefully.
Special Reminder: Do not choose a hospital based solely on social media recommendations. It is advisable to verify the hospital's operating license and laboratory qualifications through independent third-party organizations (e.g., the Thai Ministry of Health website, international certification verification platforms). If possible, arrange an online consultation with a doctor to discuss the plan directly.

===== Module D: Differences by Age Group =====

5. Differences by Age Group: Age Determines the Upper Limit of Cost-Effectiveness

Age is the most critical variable affecting IVF success rates and directly determines the cost-effectiveness of seeking treatment abroad.

Age Domestic Live Birth Rate (Reference) Thailand Live Birth Rate (Reference) Cost-Effectiveness Assessment
≤ 35 years 55% - 65% 60% - 70% Higher in China, unless PGT is needed
36 - 40 years 40% - 55% 45% - 60% Little difference; depends on ovarian reserve
41 - 42 years 20% - 35% 30% - 45% Thailand may have a slight advantage, but careful evaluation is needed
≥ 43 years 10% - 20% 15% - 25% Success rates drop significantly regardless of location; cost-effectiveness needs rational consideration

For patients over 38 years old with AMH ≤ 1.0 ng/mL who have already experienced 1-2 failures in China, changing the laboratory environment and stimulation protocol might bring a turning point. Thai hospitals have more experience with protocols like mild stimulation, luteal phase stimulation, and dual stimulation. The cost-effectiveness is relatively higher for this group.

===== Module G: Most Easily Overlooked Details =====

6. Most Easily Overlooked Details: Hidden Costs and Legal Issues

The following details are often underestimated in decision-making but have a significant actual impact:

  • Passport Validity: An IVF cycle in Thailand typically requires a stay of 20-30 days, and your passport must be valid for at least 6 months. Some hospitals require the original passports of both spouses for filing.
  • Test Report Validity: Chromosome tests and infectious disease screenings (HIV, Hepatitis B, Syphilis, etc.) are usually valid for 6 months, while AMH and semen analysis are valid for 3-6 months. If the time between testing and the planned cycle is too long, retesting will be needed, adding time and cost.
  • Male Partner Tests: The male partner needs at least a semen analysis (including morphology and DNA fragmentation), infectious disease screening, and chromosome karyotype. If sperm quality is abnormal, medication or surgical sperm retrieval may be needed in advance.
  • Genetic Counseling: If there is a family history of genetic disorders, genetic counseling and PGT-M probe design must be completed in advance, a process that takes about 2-3 months. This preparation cannot be done last minute before departure.
  • Hysteroscopy: For those with repeated implantation failure or abnormal endometrium on ultrasound, it is recommended to complete a hysteroscopy before going to Thailand to rule out issues like polyps, adhesions, or endometritis.

Timeline Suggestions:

• 3-6 months before the plan: Complete chromosome tests, AMH, semen analysis, and infectious disease screening for both partners;

• 2-3 months before the plan: Genetic counseling (if needed), hysteroscopy, passport application/renewal;

• 1 month before the plan: Set up your file at the Thai hospital, submit test reports, and finalize the stimulation protocol.

===== Module O: Suitable Candidates =====

7. Suitable Candidates: Who is More Likely to Benefit from IVF in Thailand

Based on clinical data and medical experience, the following groups tend to find higher cost-effectiveness with IVF in Thailand:

  • Those needing PGT technology: Patients with a clear genetic history, chromosomal balanced translocation, recurrent miscarriage, or advanced age (≥38 years) wishing to screen for aneuploidy. PGT technology in Thailand is mature, and cycle scheduling is more flexible than in China.
  • Those with repeated implantation failure in China: Patients who have had more than 2 transfers of good-quality embryos in China without pregnancy and are considering differences in lab environment or protocols.
  • Those with Poor Ovarian Response (POR): Patients with low AMH and few antral follicles, for whom egg donation is suggested in China, but who wish to try using their own eggs. Thailand has extensive experience with mild stimulation and natural cycles.
  • Those seeking privacy in the process: Some patients do not want their workplace or acquaintances to know, and overseas treatment can offer greater privacy protection.
  • Those with flexible schedules: Individuals who can stay in Thailand for 20-30 consecutive days or are willing to make separate trips (one for stimulation, one for transfer).

Unsuitable candidates: Patients with normal ovarian function, no genetic needs, and who can be scheduled normally at a top-tier public hospital in China. Completing treatment in China is more efficient and economical, avoiding the additional costs of language, accommodation, and transportation associated with going abroad.

===== Module Q: Frequently Asked Questions =====

8. Frequently Asked Questions: Common Patient Queries

Q1: Can I still go to Thailand for IVF with low AMH?

Yes, but you need to adjust your expectations. Low AMH doesn't mean there is no chance, but the number of eggs retrieved may be low. Thai doctors will design mild stimulation or natural cycle protocols based on AMH, FSH, and antral follicle count, aiming to obtain quality embryos with minimal medication. For patients with AMH ≤ 0.5 ng/mL, it is advisable to mentally prepare for the possibility of needing multiple cycles to accumulate embryos.

Q2: What preparations are needed for advanced age (≥40 years) going to Thailand?

In addition to routine tests, it is recommended to complete ECG, thyroid function, Vitamin D, blood glucose, and HbA1c tests. The risk of egg aneuploidy increases with age, and PGT-A screening offers clear benefits. Also, assess endometrial receptivity, and consider ERA (Endometrial Receptivity Array) if necessary.

Q3: Is pre-treatment preparation needed before IVF in Thailand?

Yes, but not through "miracle drugs" or "preparation packages." Evidence-based interventions include: supplementing with folic acid (400-800 μg/day) for at least 3 months, weight control (BMI ≤ 25), smoking and alcohol cessation, and regular sleep. For patients with Vitamin D deficiency or thyroid dysfunction, these should be corrected in advance. Antioxidants (CoQ10, DHEA, etc.) may be beneficial for some, but individual responses vary, so use them under medical advice.

Q4: How to prepare documents for IVF in Thailand?

Passports of both spouses (valid for at least 6 months), marriage certificate (some hospitals require a notarized translation), and all previous test reports. If using donor sperm or eggs, a legal donation agreement is required. Thailand has requirements regarding marital status; unmarried or same-sex couples cannot legally undergo IVF treatment in Thailand at present.

Q5: What tests should I do first before going to Thailand for the first time?

Female: AMH, FSH, LH, Estradiol, Antral Follicle Count (via vaginal ultrasound), Thyroid function, Infectious disease panel (8 items), Chromosome karyotype, Complete blood count, Coagulation profile. Male: Semen analysis (including morphology and DNA fragmentation), Infectious disease panel (8 items), Chromosome karyotype. It is recommended to complete these tests at a top-tier public hospital in China; Thai hospitals generally accept reports within 3 months.

===== Closing: Risk Reminder =====


⚠ Risk Reminder

Any IVF treatment carries uncertainties, including poor response to stimulation, no transferable embryos, implantation failure, and miscarriage. IVF in Thailand is not a "guaranteed success" option. Medical decisions should be based on your own health status and objective data. It is advisable to communicate thoroughly with your reproductive doctor before starting and develop backup plans (e.g., embryo accumulation strategy, frozen embryo transfer plan). Do not overlook medical risks due to "cost-effectiveness" expectations, nor dismiss the entire value after a single failure. Rational evaluation and scientific decision-making represent the best "cost-effectiveness."

Knowledge Base ID: ART-2025-0412  |  Content Review: Reproductive Medicine Editorial Team
在线咨询
ONLINE CONSULTATION
泰国代孕网在线咨询二维码-免费获取试管婴儿方案
扫码加客服免费得
4000600670